Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Bravaccini

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Applied Physiology|June 25, 2025
Knee pain and gait alterations: bridging physiology, biomechanics, and clinical practiceFrancesco Pegreffi, Giuliana Mannino, Sara Bravaccini, et al.
Arthroplasty Today|May 9, 2025
Expanding the Horizon of Multidisciplinarity: Incorporating Biomechanical, Metabolic, and Functional Factors Into Registry-Based Research to Predict Subsequent Risk for Total Knee ArthroplastyFrancesco Pegreffi, Maria Tiziana Di Leo, Giuseppe Fanzone, et al.
Molecular Biology Reports|December 7, 2024
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitroEssi Parviainen, Sini Nurmenniemi, Sara Ravaioli, et al.
Biological Reviews of the Cambridge Philosophical Society|April 20, 2018
Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancerGiuseppe Bronte, Sara Bravaccini, Enrico Bronte, et al.
Histopathology|June 27, 2018
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?Maurizio Puccetti, Sara Ravaioli, Maria M Tumedei, et al.
Expert Opinion on Therapeutic Targets|August 13, 2022
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancerMichela Cortesi, Michele Zanoni, Roberta Maltoni, et al.
Therapeutic Advances in Medical Oncology|February 17, 2017
Progress with palbociclib in breast cancer: latest evidence and clinical considerationsAndrea Rocca, Alessio Schirone, Roberta Maltoni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2025
FAP inhibitors: are we really using the best method to evaluate the residence time?Michela Cortesi, Remo Guerrini, Chiara Roccatello, et al.
Medicine|June 17, 2020
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case reportRoberta Maltoni, Michela Palleschi, Giulia Gallerani, et al.
Annals of Global Health|August 26, 2021
Setting Up a Medical Oncology Educational Program in Sub-Saharan AfricaSara Bravaccini, Patrizia Serra, Dino Amadori, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Applied Physiology|June 25, 2025
Knee pain and gait alterations: bridging physiology, biomechanics, and clinical practiceFrancesco Pegreffi, Giuliana Mannino, Sara Bravaccini, et al.
Arthroplasty Today|May 9, 2025
Expanding the Horizon of Multidisciplinarity: Incorporating Biomechanical, Metabolic, and Functional Factors Into Registry-Based Research to Predict Subsequent Risk for Total Knee ArthroplastyFrancesco Pegreffi, Maria Tiziana Di Leo, Giuseppe Fanzone, et al.
Molecular Biology Reports|December 7, 2024
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitroEssi Parviainen, Sini Nurmenniemi, Sara Ravaioli, et al.
Biological Reviews of the Cambridge Philosophical Society|April 20, 2018
Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancerGiuseppe Bronte, Sara Bravaccini, Enrico Bronte, et al.
Histopathology|June 27, 2018
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?Maurizio Puccetti, Sara Ravaioli, Maria M Tumedei, et al.
Expert Opinion on Therapeutic Targets|August 13, 2022
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancerMichela Cortesi, Michele Zanoni, Roberta Maltoni, et al.
Therapeutic Advances in Medical Oncology|February 17, 2017
Progress with palbociclib in breast cancer: latest evidence and clinical considerationsAndrea Rocca, Alessio Schirone, Roberta Maltoni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2025
FAP inhibitors: are we really using the best method to evaluate the residence time?Michela Cortesi, Remo Guerrini, Chiara Roccatello, et al.
Medicine|June 17, 2020
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case reportRoberta Maltoni, Michela Palleschi, Giulia Gallerani, et al.
Annals of Global Health|August 26, 2021
Setting Up a Medical Oncology Educational Program in Sub-Saharan AfricaSara Bravaccini, Patrizia Serra, Dino Amadori, et al.
Pageof 15